Nutritional Assessment in Children With Cardiomyopathy

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-18
SponsorAssiut University

About this trial

This cross-sectional study aims to determine the prevalence and pattern of malnutrition (acute wasting, chronic stunting, and micronutrient deficiency) among children with cardiomyopathy attending the Pediatric Cardiology Unit at Assiut University Children's Hospital.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children aged 1 month to 18 years.

Established diagnosis of cardiomyopathy (dilated, hypertrophic, or restrictive) confirmed by echocardiography.

Attending or admitted to the Pediatric Cardiology Unit at Assiut University Children's Hospital.

Written informed consent from parent/legal guardian.

Disqualifiers

Known chronic conditions with an independent, primary effect on nutritional status (e.g., celiac disease, chronic kidney disease, malignancy).

Genetic/metabolic syndromes with intrinsic growth failure unrelated to cardiac status.

Refusal of parental/guardian informed consent.

Trial population

Children aged 1 month to 18 years with an established diagnosis of cardiomyopathy (dilated, hypertrophic, or restrictive) confirmed by echocardiography, attending or admitted to the Pediatric Cardiology Unit at Assiut University Children's Hospital.

Trial design

Design model

Case-only

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

108 Participants
are grouped into 1 trial group
Group A: Children With Cardiomyopathy

Trial outcomes

Primary outcomes

1

Title: Prevalence of malnutrition

Proportion of children with cardiomyopathy who have malnutrition based on anthropometric z-scores according to WHO growth standards.

Time frame
Baseline

Secondary outcomes

1

Proportion of children at nutritional risk by STRONGkids

Proportion of children classified as at nutritional risk according to the STRONGkids screening tool.

Time frame
Baseline
2

Mean left ventricular ejection fraction

Mean left ventricular ejection fraction (LVEF) measured by echocardiography in percentage.

Time frame
Baseline
3

Mean serum albumin

Mean serum albumin level in g/dL.

Time frame
Baseline
4

Mean body mass index for age z-score

Mean BMI-for-age z-score according to WHO growth standards.

Time frame
Baseline

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: